List of Tables
Table 1. Global Endothelin Antagonists Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Endothelin Antagonists Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Endothelin Antagonists Therapeutics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Endothelin Antagonists Therapeutics Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Endothelin Antagonists Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Endothelin Antagonists Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Endothelin Antagonists Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Endothelin Antagonists Therapeutics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Endothelin Antagonists Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Endothelin Antagonists Therapeutics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Endothelin Antagonists Therapeutics, Product Type & Application
Table 12. Global Key Manufacturers of Endothelin Antagonists Therapeutics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Endothelin Antagonists Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelin Antagonists Therapeutics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Endothelin Antagonists Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Endothelin Antagonists Therapeutics Sales by Region (2020-2025) & (K Units)
Table 18. Global Endothelin Antagonists Therapeutics Sales Market Share by Region (2020-2025)
Table 19. Global Endothelin Antagonists Therapeutics Sales by Region (2026-2031) & (K Units)
Table 20. Global Endothelin Antagonists Therapeutics Sales Market Share by Region (2026-2031)
Table 21. Global Endothelin Antagonists Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Endothelin Antagonists Therapeutics Revenue Market Share by Region (2020-2025)
Table 23. Global Endothelin Antagonists Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Endothelin Antagonists Therapeutics Revenue Market Share by Region (2026-2031)
Table 25. North America Endothelin Antagonists Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Endothelin Antagonists Therapeutics Sales by Country (2020-2025) & (K Units)
Table 27. North America Endothelin Antagonists Therapeutics Sales by Country (2026-2031) & (K Units)
Table 28. North America Endothelin Antagonists Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Endothelin Antagonists Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Endothelin Antagonists Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Endothelin Antagonists Therapeutics Sales by Country (2020-2025) & (K Units)
Table 32. Europe Endothelin Antagonists Therapeutics Sales by Country (2026-2031) & (K Units)
Table 33. Europe Endothelin Antagonists Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Endothelin Antagonists Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Endothelin Antagonists Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Endothelin Antagonists Therapeutics Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Endothelin Antagonists Therapeutics Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Endothelin Antagonists Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Endothelin Antagonists Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Endothelin Antagonists Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Endothelin Antagonists Therapeutics Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Endothelin Antagonists Therapeutics Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Endothelin Antagonists Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Endothelin Antagonists Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Endothelin Antagonists Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Endothelin Antagonists Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Endothelin Antagonists Therapeutics Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Endothelin Antagonists Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Endothelin Antagonists Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Endothelin Antagonists Therapeutics Sales (K Units) by Type (2020-2025)
Table 51. Global Endothelin Antagonists Therapeutics Sales (K Units) by Type (2026-2031)
Table 52. Global Endothelin Antagonists Therapeutics Sales Market Share by Type (2020-2025)
Table 53. Global Endothelin Antagonists Therapeutics Sales Market Share by Type (2026-2031)
Table 54. Global Endothelin Antagonists Therapeutics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Endothelin Antagonists Therapeutics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Endothelin Antagonists Therapeutics Revenue Market Share by Type (2020-2025)
Table 57. Global Endothelin Antagonists Therapeutics Revenue Market Share by Type (2026-2031)
Table 58. Global Endothelin Antagonists Therapeutics Price (US$/Unit) by Type (2020-2025)
Table 59. Global Endothelin Antagonists Therapeutics Price (US$/Unit) by Type (2026-2031)
Table 60. Global Endothelin Antagonists Therapeutics Sales (K Units) by Application (2020-2025)
Table 61. Global Endothelin Antagonists Therapeutics Sales (K Units) by Application (2026-2031)
Table 62. Global Endothelin Antagonists Therapeutics Sales Market Share by Application (2020-2025)
Table 63. Global Endothelin Antagonists Therapeutics Sales Market Share by Application (2026-2031)
Table 64. Global Endothelin Antagonists Therapeutics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Endothelin Antagonists Therapeutics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Endothelin Antagonists Therapeutics Revenue Market Share by Application (2020-2025)
Table 67. Global Endothelin Antagonists Therapeutics Revenue Market Share by Application (2026-2031)
Table 68. Global Endothelin Antagonists Therapeutics Price (US$/Unit) by Application (2020-2025)
Table 69. Global Endothelin Antagonists Therapeutics Price (US$/Unit) by Application (2026-2031)
Table 70. Gilead Sciences, Inc Company Information
Table 71. Gilead Sciences, Inc Description and Business Overview
Table 72. Gilead Sciences, Inc Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Gilead Sciences, Inc Endothelin Antagonists Therapeutics Product
Table 74. Gilead Sciences, Inc Recent Developments/Updates
Table 75. Sun Pharmaceutical Industries Ltd Company Information
Table 76. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 77. Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Product
Table 79. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 80. Lupin Company Information
Table 81. Lupin Description and Business Overview
Table 82. Lupin Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Lupin Endothelin Antagonists Therapeutics Product
Table 84. Lupin Recent Developments/Updates
Table 85. Zydus Group Company Information
Table 86. Zydus Group Description and Business Overview
Table 87. Zydus Group Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Zydus Group Endothelin Antagonists Therapeutics Product
Table 89. Zydus Group Recent Developments/Updates
Table 90. Endo International plc Company Information
Table 91. Endo International plc Description and Business Overview
Table 92. Endo International plc Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Endo International plc Endothelin Antagonists Therapeutics Product
Table 94. Endo International plc Recent Developments/Updates
Table 95. Mylan NV Company Information
Table 96. Mylan NV Description and Business Overview
Table 97. Mylan NV Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Mylan NV Endothelin Antagonists Therapeutics Product
Table 99. Mylan NV Recent Developments/Updates
Table 100. Teva Pharmaceutical Industries Ltd Company Information
Table 101. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 102. Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Product
Table 104. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 105. Sigmapharm Laboratories , LLC Company Information
Table 106. Sigmapharm Laboratories , LLC Description and Business Overview
Table 107. Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Product
Table 109. Sigmapharm Laboratories , LLC Recent Developments/Updates
Table 110. Alembic Pharmaceuticals Limited Company Information
Table 111. Alembic Pharmaceuticals Limited Description and Business Overview
Table 112. Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Product
Table 114. Alembic Pharmaceuticals Limited Recent Developments/Updates
Table 115. Hikma Pharmaceuticals PLC Company Information
Table 116. Hikma Pharmaceuticals PLC Description and Business Overview
Table 117. Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Product
Table 119. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 120. Amneal Pharmaceuticals LLC Company Information
Table 121. Amneal Pharmaceuticals LLC Description and Business Overview
Table 122. Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Product
Table 124. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 125. AstraZeneca Company Information
Table 126. AstraZeneca Description and Business Overview
Table 127. AstraZeneca Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. AstraZeneca Endothelin Antagonists Therapeutics Product
Table 129. AstraZeneca Recent Developments/Updates
Table 130. Johnsons & Johnsons Private limited Company Information
Table 131. Johnsons & Johnsons Private limited Description and Business Overview
Table 132. Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Product
Table 134. Johnsons & Johnsons Private limited Recent Developments/Updates
Table 135. GSK Plc Company Information
Table 136. GSK Plc Description and Business Overview
Table 137. GSK Plc Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. GSK Plc Endothelin Antagonists Therapeutics Product
Table 139. GSK Plc Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Endothelin Antagonists Therapeutics Distributors List
Table 143. Endothelin Antagonists Therapeutics Customers List
Table 144. Endothelin Antagonists Therapeutics Market Trends
Table 145. Endothelin Antagonists Therapeutics Market Drivers
Table 146. Endothelin Antagonists Therapeutics Market Challenges
Table 147. Endothelin Antagonists Therapeutics Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Endothelin Antagonists Therapeutics
Figure 2. Global Endothelin Antagonists Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Endothelin Antagonists Therapeutics Market Share by Type: 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Parenteral Product Picture
Figure 6. Global Endothelin Antagonists Therapeutics Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Endothelin Antagonists Therapeutics Market Share by Application: 2024 & 2031
Figure 8. Cardiovascular Diseases
Figure 9. Scleroderma
Figure 10. Other
Figure 11. Global Endothelin Antagonists Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Endothelin Antagonists Therapeutics Market Size (2020-2031) & (US$ Million)
Figure 13. Global Endothelin Antagonists Therapeutics Sales (2020-2031) & (K Units)
Figure 14. Global Endothelin Antagonists Therapeutics Average Price (US$/Unit) & (2020-2031)
Figure 15. Endothelin Antagonists Therapeutics Report Years Considered
Figure 16. Endothelin Antagonists Therapeutics Sales Share by Manufacturers in 2024
Figure 17. Global Endothelin Antagonists Therapeutics Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Endothelin Antagonists Therapeutics Players: Market Share by Revenue in Endothelin Antagonists Therapeutics in 2024
Figure 19. Endothelin Antagonists Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Endothelin Antagonists Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Endothelin Antagonists Therapeutics Sales Market Share by Country (2020-2031)
Figure 22. North America Endothelin Antagonists Therapeutics Revenue Market Share by Country (2020-2031)
Figure 23. United States Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Endothelin Antagonists Therapeutics Sales Market Share by Country (2020-2031)
Figure 26. Europe Endothelin Antagonists Therapeutics Revenue Market Share by Country (2020-2031)
Figure 27. Germany Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Endothelin Antagonists Therapeutics Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Endothelin Antagonists Therapeutics Revenue Market Share by Region (2020-2031)
Figure 34. China Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Endothelin Antagonists Therapeutics Sales Market Share by Country (2020-2031)
Figure 42. Latin America Endothelin Antagonists Therapeutics Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Endothelin Antagonists Therapeutics Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Endothelin Antagonists Therapeutics Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Endothelin Antagonists Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Endothelin Antagonists Therapeutics by Type (2020-2031)
Figure 52. Global Revenue Market Share of Endothelin Antagonists Therapeutics by Type (2020-2031)
Figure 53. Global Endothelin Antagonists Therapeutics Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Endothelin Antagonists Therapeutics by Application (2020-2031)
Figure 55. Global Revenue Market Share of Endothelin Antagonists Therapeutics by Application (2020-2031)
Figure 56. Global Endothelin Antagonists Therapeutics Price (US$/Unit) by Application (2020-2031)
Figure 57. Endothelin Antagonists Therapeutics Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
